Corticosteroids restore the balance between locally produced Th1 and Th2 cytokines and immunoglobulin isotypes to normal in sarcoid lung

Clinical and Experimental Immunology

Volumn 108, Issue 1, 1997, Pages 105-113

  Milburn, H J ^a   Poulter, L W ^b   Dilmec, A ^a   Cochrane, G M ^a   Kemeny, D M ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Bronchoalveolar lavage; Corticosteroids; Sarcoidosis; Th1 Th2

Indexed keywords

CORTICOSTEROID; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN 2; INTERLEUKIN 4;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HELPER CELL; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOREGULATION; LUNG LAVAGE; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SARCOIDOSIS; T LYMPHOCYTE SUBPOPULATION;

EID: 0030977728     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.d01-979.x     Document Type: Article

References (53)

1. Mitchell DW, Rees RJW. Sartoidosis. Oxford: Pergamon Press, 1983: 132.
2. Hills SE, Parkes SA, Baker SB. Epidemiology of sarcoidosis in the Isle of Man - 2: Evidence for space-lime clustering. Thorax 1987; 42:427-30.
3. Pasturenzi L, Martinetti M, Cuccia M, Cipriani A, Semenzato G, Luisetti M, the Pavia-Padova Sarcoidosis Study Group. HLA class I, II and III polymorphism in Italian patients with sarcoidosis. Chest 1993; 104:1170-5.
4. Abe S, Yamaguchi E, Makimura S, Okazaki N, Kunikane H, Kawakami Y. Association of HLA-DR with sarcoidosis: correlation with clinical course. Chest 1987; 92:488-90.
5. Mosmann TR, Cherwinski H, Bond MW, Gieldin MA, Coffman RL. Two types of murine helper T cell clones. J Immunol 1986; 136:234-57.
6. + T lymphocytes in atopic patients. J Immunol 1990; 144:4651-6.
7. Del Prete G-F, De Carli M, Mastomauro C, Macchia D, Biagotti R, Ricci M, Romagnani S. Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigens of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J Clin Invest 1991 ; 88:346-50.
8. Parronchi P, Macchia D, Piccinni MP et al. Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. PNAS 1991; 88:4538-42.
9. Romagnani S. Human Th1 and Th2 subsets: doubt no more. Immunol Today 1991; 12:256-7.
10. Wierenga EA, Snoek M, Bos JD, Jansen HM, Kapsenberg ML. Comparison of diversity and function of house dust mite-specific T lymphocyte clones from atopic and non-atopic donors. Eur J Immunol 1990; 20:1519-26.
11. Aversa G, Punnonen J, Cocks BG, de Waal Malefyt R, Vega F Jr, Zurawski SM, Zurawski S, de Vries JE. An interleukin 4 (IL-4) mutant protein inhibits both IL-4 or IL-13 induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: support for a common component shared by IL-4 and IL-13 receptors. J Exp Med 1993; 178:2213-8.
12. Kay AB, Sun Y, Varney V, Gaga M, Durham SR, Moqbel R, Wardlaw AJ, Humid Q. Messenger RNA expression of the cytokine gene cluster interleukin-3 (IL-3), IL-4, IL-5 and granulocyte/macrophage colony-stimulating factor in allergen-induced late-phase cutaneous reactions in atopic subjects. J Exp Med 1991; 173:775-8.
13. Durham SR, Sun Y, Varney VA, Jacobson MR, Sudderick RM, Mackay IS, Kay AB, Hamid Q. Cytokine messenger RNA expression for IL-3, IL-4, IL-5 and granulocyte/macrophage colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J Immunol 1992; 148:2390-4.
14. Robinson DS, Hamid Q, Sun Y et al. Predominant Th2-like bronchoalveolar T lymphocyte population in atopic asthma. N Engl J Med 1992; 326:298-304.
15. Haanen JBAG, de Waal Malefijt R, Res PCM, Kraakman EM, Ottenhoff THM, de Vries RRP, Spits H. Selection of human T helper I-like T cell subset by mycobacteria. J Exp Med 1991; 174:583-92.
16. +) in classical delayed-type (tuberculin) hypersensitivity reactions in human skin. J Immunol 1992; 148:2058-61.
17. Robinson DS, Sun Y, Taylor IK, Wangoo A, Milchell DM, Kay AB, Hamid Q, Show RJ. Evidence for a Th1-like bronchoalveolar T-cell subset and predominance of interferon-gamma gene activation in pulmonary tuberculosis. Am J Respir Crit Care Med 1994; 149:989-93.
18. Robinson BWS, McLemore TL, Crystal RG. Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis. J Clin Invest 1985; 75:1488-95.
19. Sahashi K, Ina Y, Takada K, Sato T, Yamamoto M, Morishita M. Significance of interleukin 6 in patients with sareoidosis. Chest 1994; 106:156-60.
20. Del Prete G, Maggi E, Parronchi P et al. IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants. J Immunol 1988; 140:419-38.
21. Van der Zee JS, Van Swieten P, Aalberse RC. Inhibition of complement activation by IgG4 antibodies. Clin Exp Immunol 1986; 64:415-22.
22. Merrill WW, Naegel GP, Olchowski JJ, Reynolds HY. Immunoglobulin G subclass proteins in serum and lavage fluid of normal subjects. Am Rev Respir Dis 1985; 131:584-7.
23. Out TA, Van der Graaf EA, Van den Berg NJ, Jansen HM. IgG subclasses in bronchoalveolar lavage fluid from patients with asthma. Scand J Immunol 1991; 33:719-27.
24. Milburn HJ, Prentice HG, Grundy JE. IgG subclasses in the lungs of patients with interstitial pneumonitis following bone marrow transplantation. Eur Respir J 1993; 6:944-50.
25. Rankin JA, Olchowski J, Naegel GP, Merrill WW, Reynolds HY. Immunoglobulin G subclasses in sarcoidosis. Ann NY Acad Sci 1986; 465:122-9.
26. Milburn HJ, Prentice HG, du Bois RM. Role of bronchoalveolar lavage in the evaluation of interstitial pneumonitis in recipients of bone marrow transplants. Thorax 1987; 42:766-72.
27. Kemeny DM, Richards D, Johannsson A, Durnin S. Ultrasensitive enzyme-linked immunosorbent assay (ELISA) for the detection of picogram quantities of IgE. J Immunol Methods 1989; 120:251-5.
28. Klech L, Pohl W (eds) for the European Society of Pneumonology Task Group on BAL. Technical recommendations and guidelines for bronchoalveolar lavage (BAL). Eur Respir J 1989; 2:561-5.
29. Wiggins J, Stockley RA. Variability in sputum sol phase proteins in chronic obstructive bronchitis. The value of using albumin for standardisation. Am Rev Respir Dis 1983; 128:60-64.
30. Beck CS, Heiner DC. Selective immunoglobulin G4 deficiency in recurrent infections of the respiratory tract. Am Rev Respir Dis 1981; 124:94-96.
31. Bentur L, Nisbet-Brown E, Levison H, Roifman CM. Lung disease associated with IgG subclass deficiency in chronic mucocutaneous candidiasis. J Paediatr 1991; 118:82-86.
32. Oxelius VA. Immunoglobulin G (IgG) subclasses and human disease. Am J Med 1984; 76:7-18.
33. Heiner DC, Lee SI, Short JA. IgG4 subclass deficiency syndromes. Monogr Allergy 1986; 20:149-56.
34. Punnonen J, Aversa G, Cocks BG, McKenzie AN, Menon S, Zurawski G, de Waal Malefyt R, de Vries JE. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci USA 1993; 90:3730-4.
35. Street NE, Mosmann TR. Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB J 1991; 5:171-7.
36. Swain SL, Weinberg AD, English M, Huston G. IL-4 directs the development of Th2-like helper effectors. J Immunol 1990; 145: 3796-806.
37. + T cells. Differential effects of IL-1 on helper and inflammatory T cells. J Immunol 1988; 140:1555-60.
38. Fernandez-Botran R, Sanders VM, Mosmann TR, Vitetta ES. Lymphocyte-mediated regulation of the proliferative response of clones of the T helper 1 and T helper 2 cells. J Exp Med 1988; 168:543-58.
39. Gajewski TF, Schell SR, Nau G, Fitch FW. Regulation of T-cell activation: differences among T cell subsets. Immunol Rev 1989; 111:79-110.
40. Bitterman PB, Saltzman LE, Adelberg S, Ferrano VJ, Crystal RG. One mechanism for the expansion of the mononuclear phagocyte population in the chronically inflamed lung. J Clin Invest 1984; 74: 460-9.
41. Pinkston P, Bitterman PB, Crystal RG. Spontaneous release of interleukin 2 by lung T lymphocytes in active pulmonary sarcoidosis. N Engl J Med 1983; 308:793-800.
42. Hunninghake GW, Bedell GH, Zavala DC, Monick M, Brady M. Role of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis. Am Rev Respir Dis 1983; 128:634-8.
43. Pinkston P, Saltini C, Muller-Quernheim J, Crystal RG. Corticosteroid therapy suppresses spontaneous interleukin-2 release and spontaneous proliferation of lung T lymphocytes of patients with active pulmonary sarcoidosis. J Immunol 1987; 139:755-60.
44. Devergne O, Emilie D, Peuchmaur M, Crevon MC, D'Agay MF, Galanaud P. Production of cytokines in sarcoid lymph nodes: preferential expression of interleukin-1 beta and interferon-gamma genes. Hum Pathol 1992; 23:317-23.
45. Akbar AN, Borthwick M, Salmon M et al. The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory. J Exp Med 1993; 178:427-38.
46. de Waal-Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10. J Exp Med 1991; 174:1209-20.
47. Ceuppens JC, Laquet LM, Marien J, Demeds M, van der Eeckhout A, Stevens E. Alveolar T-cell subsets in pulmonary sarcoidosis. Correlations with disease activity and effect of steroid treatment. Am Rev Respir Dis 1984; 129:563-8.
48. Hance AJ, Douches S, Winchester RJ, Ferrans VJ, Crystal RG. Characterisation of mononuclear phagocyte subpopulations in the human lung by using monoclonal antibodies. Changes in alveolar macrophage phenotype associated with pulmonary sarcoidosis. J Immunol 1985; 134:284-92.
49. Ton CM, van Maarseveen T, Mullink H, Stam J, de Groot J. Macrophage-T suppressor cell interference in the lungs of steroid-treated sarcoidosis patients. Am Rev Respir Dis 1991; 143:839-43.
50. Baughman RP, Lower EE. The effect of Corticosteroid or methotrexate therapy on lung lymphocytes and macrophages in sarcoidosis. Am Rev Respir Dis 1990; 142:1268-71.
51. Spatafora M, Mirabella A, Rossi G, Bonanno A, Riccobono L, Merendino A, Bellia V, Bonsignore G. Effects of oral steroids on immunoglobulins in bronchoalveolar lavage fluid in active sarcoidosis. Eur Respir J 1988; 1:505-9.
52. Prior C, Haslam PL. Increased levels of serum interferon-gamma in pulmonary sarcoidosis and relationship with response to Corticosteroid therapy. Am Rev Respir Dis 1991; 143:53-60.
53. Wu CY, Safarti M, Heusser C, Fournier S, Rubio-Trujillo M, Peleman R, Delespesse G. Glucocorticoids increase the synthesis of immunoglobulin E by interleukin-4-stimulated human lymphocytes. J Clin Invest 1991; 87:870-7.